Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

94.85
Delayed Data
As of Jun 27
 -1.44 / -1.50%
Today’s Change
92.98
Today|||52-Week Range
140.72
-20.80%
Year-to-Date
When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?
Jun 27 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
Better Buy: Bellicum Pharmaceuticals, Inc. vs. Juno Therapeutics, Inc.
Jun 26 / MotleyFool.com - Paid Partner Content
Why Investors Are Paying a Premium for These 3 Drugmakers
Jun 24 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Celgene Corporation
Jun 23 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
Prima Reports Favorable Initial Breast Cancer Study Data
Jun 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close96.29
Today’s open95.56
Day’s range94.42 - 96.78
Volume6,589,851
Average volume (3 months)4,725,533
Market cap$74.6B
Dividend yield--
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.78%
Earnings growth (next 5 years)+23.20%
Revenue growth (last year)+16.47%
P/E ratio46.1
Price/Sales11.10
Price/Book12.80

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.09+0.32%
LLYEli Lilly and Co+0.56+0.75%
AGNAllergan-8.24-3.65%
ABTAbbott Laboratories-0.96-2.53%
Data as of 4:06pm ET, 06/27/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.39
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

Search for Jobs